Search results for "Pain measurement"

showing 10 items of 358 documents

Differential effects on the laser evoked potential of selectively attending to pain localisation versus pain unpleasantness

2004

Abstract Objective : To determine the effects on the laser evoked potential (LEP) of selectively attending to affective (unpleasantness) versus sensory-discriminative (localisation) components of pain. Methods : LEPs, elicited by painful CO 2 laser stimulation of two areas of the right forearm, were recorded from 62 electrodes in 21 healthy volunteers, during three tasks that were matched for generalised attention: Localisation (report stimulus location), Unpleasantness (report stimulus unpleasantness), Control (report pain detection). LEP components are named by polarity, latency, and electrode. Results : N300-T7 peak amplitude was significantly greater during Localisation than Unpleasantn…

AdultMalemedicine.medical_specialtyLaser-Evoked PotentialsPainAudiologyStimulus (physiology)Somatosensory systemEvoked Potentials SomatosensoryPhysiology (medical)Reaction TimeNoxious stimulusmedicineHumansAttentionEvoked potentialPain MeasurementAnalysis of VarianceSecondary somatosensory cortexLasersSensory SystemsNeurologySomatosensory evoked potentialFemaleNeurology (clinical)PsychologyInsulaNeuroscienceClinical Neurophysiology
researchProduct

Revised Definition of Neuropathic Pain and Its Grading System: An Open Case Series Illustrating Its Use in Clinical Practice

2009

The definition of neuropathic pain has recently been revised by an expert committee of the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (NeuPSIG) as "pain arising as direct consequence of a lesion or disease affecting the somatosensory system," and a grading system of "definite," "probable," and "possible" neuropathic pain has been introduced. This open case series of 5 outpatients (3 men, 2 women; mean age 48 +/- 12 years) demonstrates how the grading system can be applied, in combination with appropriate confirmatory testing, to diagnosis neuropathic conditions in clinical practice. The proposed grading system includes a dynamic algorithm …

AdultMalemedicine.medical_specialtyMEDLINEPainPhysical examinationDiseaseNeurological disorderSeverity of Illness IndexDiagnosis DifferentialCraniomandibular DisordersBrown-Sequard SyndromeSeverity of illnessmedicineHumansMedical History TakingSomatoform DisordersProspective cohort studyPhysical ExaminationPain Measurementmedicine.diagnostic_testbusiness.industryNeuromyelitis OpticaGeneral MedicineMiddle AgedTrigeminal Neuralgiamedicine.diseaseSurgeryNeuropathic painNeuralgiaPhysical therapyNeuralgiaFemaleUlnar NeuropathiesbusinessThe American Journal of Medicine
researchProduct

Magnetic resonance and ultrasound in achilles tendinopathy: Predictive role and response assessment to platelet-rich plasma and adipose-derived strom…

2017

To assess the correlation between magnetic resonance and ultrasound findings and clinical outcome after intratendinous injection of leucocyte-rich platelet-rich plasma or adipose-derived stromal vascular fraction in patients with non-insertional Achilles tendinopathy.Forty-three patients (age: 47.8±5.1, range 29-55) with unilateral or bilateral non-insertional Achilles tendinopathy (58 tendons overall) were randomly assigned to platelet-rich plasma (22 patients, 28 tendons) or adipose-derived stromal vascular fraction (21 patients, 30 tendons) injection group. All patients underwent magnetic resonance (tendon cross-sectional area, signal intensity, maximum anteroposterior thickness were mea…

AdultMalemedicine.medical_specialtyMagnetic Resonance SpectroscopyIntraclass correlationVisual analogue scaleAdipose-tissue stromal vascular fractionAchilles TendonInjections030218 nuclear medicine & medical imaging03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineVisual analogue scaleNuclear Medicine and ImagingUltrasoundHumansMedicineRadiology Nuclear Medicine and imagingObesityPain MeasurementUltrasonographyAnalysis of Variance030222 orthopedicsAchilles tendonmedicine.diagnostic_testPlatelet-Rich Plasmabusiness.industryUltrasoundMagnetic resonance imagingGeneral MedicineMiddle AgedStromal vascular fractionmedicine.diseaseTendonTreatment Outcomemedicine.anatomical_structureAdipose TissueTendinopathyFemaleRadiologyStromal CellsTendinopathyRadiologybusinessAdipose-tissue stromal vascular fraction; Magnetic resonance imaging; Platelet-rich plasma; Ultrasound; Visual analogue scale; Radiology Nuclear Medicine and ImagingEuropean Journal of Radiology
researchProduct

Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial.

2007

PURPOSE: The maximum resting pressure in the anal canal is greatly raised after hemorrhoidectomy. This increase is likely to be the cause of postoperative pain, which is still the most troublesome early problem after hemorrhoidectomy. This study was designed to compare, after hemorrhoidectomy, the effects of intrasphincter injection of botulinum toxin vs. application of glyceryl trinitrate ointment in improving wound heating and reducing postoperative pain at rest or during defecation. METHODS: Thirty patients with hemorrhoids of third and fourth degree were included in the study and randomized in two groups. Anorectal manometry was performed preoperatively and 5 and 40 days after hemorrhoi…

AdultMalemedicine.medical_specialtyManometryRestMULTICENTERPLACEBO-CONTROLLED TRIALHemorrhoidslaw.inventionInjectionsOintmentsNITROGLYCERIN OINTMENTNitroglyceringlyceryl trinitrateHemorrhoidsHEADACHERandomized controlled triallawmedicineHumansbotulinum toxinBotulinum Toxins Type AAdverse effectDefecationNEURONSPain MeasurementPain PostoperativeNITRIC-OXIDEhemorrhoidectomy CHRONIC ANAL-FISSUREbusiness.industryAnorectal manometryGastroenterologyGeneral MedicineAnal canalmedicine.diseaseDOUBLE-BLIND TRIALBotulinum toxinColorectal surgerySurgerymedicine.anatomical_structureTreatment OutcomeSPHINCTEROTOMYNeuromuscular AgentsAnesthesiaDefecationFemalebusinessmedicine.drugDiseases of the colon and rectum
researchProduct

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients

2013

Abstract Aims The present study was undertaken to investigate the relationship between glyoxalase 1 (Glo1) enzyme activity and painful diabetic neuropathy (DN) in patients with diabetes mellitus. Methods Glo1 activity and biochemical markers were determined in blood samples from 108 patients with type 1 diabetes, 109 patients with type 2 diabetes, and 132 individuals without diabetes as a control. Painful and painless peripheral DN was assessed and multivariate regression analysis was used to determine independent association of Glo1 activity with occurrence of painful DN. Results In patients with type 1 and type 2 diabetes mellitus and painful DN compared to patients with painless DN, Glo1…

AdultMalemedicine.medical_specialtyMultivariate analysisEndocrinology Diabetes and MetabolismPainType 2 diabetesSeverity of Illness IndexGastroenterologyEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansPain MeasurementGlycated HemoglobinType 1 diabetesbusiness.industryConfoundingLactoylglutathione LyasePeripheral Nervous System DiseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasePeripheralDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Painful diabetic neuropathyDisease ProgressionFemalebusinessBiomarkersJournal of Diabetes and its Complications
researchProduct

Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.

2003

Botulinum toxin A (BoNT/A) has been used therapeutically to treat muscular hypercontractions and sudomotor hyperactivity. There is increasing evidence that BoNT/A might also have analgesic properties, in particular in headache. In the present investigation we tested the often cited hypothesis that BoNT/A-induced analgesia can be attributed to inhibition of neuropeptide release from nociceptive nerve fibers. In 15 healthy volunteers BoNT/A (5, 10, 20 mouse units BOTOX) or saline (contralateral side) was injected intracutaneously on the volar forearm. On day zero, the day of injection, no further tests were performed. We repeatedly elicited pain, mechanical hyperalgesia and neurogenic flare b…

AdultMalemedicine.medical_specialtyNeurologyAnalgesicNeuropeptidePainStimulationNerve FibersPsychophysicsMedicineHumansBotulinum Toxins Type APain MeasurementSkinHypohidrosisNeurogenic inflammationbusiness.industryNociceptorsAxonsElectric StimulationSudomotorNociceptionNeurologyHyperalgesiaAnesthesiaHyperalgesiaFemaleNeurology (clinical)medicine.symptomNeurogenic InflammationbusinessJournal of neurology
researchProduct

Modulation of pain perception by transcranial magnetic stimulation of left prefrontal cortex.

2010

Evidence by functional imaging studies suggests the role of left dorsolateral prefrontal cortex (DLPFC) in the inhibitory control of nociceptive transmission system. Repetitive transcranial magnetic stimulation (rTMS) is able to modulate pain response to capsaicin. In the present study, we evaluated the effect of DLPFC activation (through rTMS) on nociceptive control in a model of capsaicin-induced pain. The study was performed on healthy subjects that underwent capsaicin application on right or left hand. Subjects judged the pain induced by capsaicin through a 0–100 VAS scale before and after 5 Hz rTMS over left and right DLPFC at 10 or 20 min after capsaicin application in two separate gr…

AdultMalemedicine.medical_specialtyNeurologyOriginalmedicine.medical_treatmentPain medicineClinical NeurologyPainPrefrontal CortexStimulationbehavioral disciplines and activitiesFunctional Lateralitymental disordersmedicineHumansPain ManagementPrefrontal cortexPain Measurementbusiness.industryNeural InhibitionGeneral MedicineMiddle Agedpain perception tms prefrontal cortexTranscranial Magnetic StimulationTranscranial magnetic stimulationFunctional imagingNociceptionAnesthesiology and Pain Medicinenervous systemBrain stimulationAnesthesiaFemaleMagnetic stimulationNeurology (clinical)Capsaicinbusinesspsychological phenomena and processesThe journal of headache and pain
researchProduct

Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis.

2015

Necrotizing fasciitis (NF) is a rare mono-/polymicrobial skin infection that spreads to underlying tissues. NF is quickly progressing and leads to life threatening situations. Immediate surgical debridement together with i.v. antibiotic administration is required to avoid fatal outcome. Early diagnosis is often delayed due to underestimation or confusion with cellulitis. We now compared the initial clinical and laboratory presentation of NF and cellulitis in detail to assess if a typical pattern can be identified that aids timely diagnosis of NF and avoidance of fatal outcome. 138 different clinical and laboratory features of 29 NF patients were compared to those of 59 age- and gender match…

AdultMalemedicine.medical_specialtyPainlcsh:MedicineSeverity of Illness IndexErysipelasDiagnosis DifferentialYoung AdultSex FactorsInternal medicineSeverity of illnessmedicineHumansFasciitis NecrotizingFasciitislcsh:ScienceAgedPain MeasurementRetrospective StudiesAged 80 and overMultidisciplinarybiologybusiness.industrySoft Tissue InfectionsC-reactive proteinlcsh:RCase-control studyCellulitisRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryC-Reactive ProteinTreatment OutcomeDebridementCase-Control StudiesCellulitisbiology.proteinFemalelcsh:QDifferential diagnosisbusinessResearch ArticlePLoS ONE
researchProduct

Personalized Pain Goals and Responses in Advanced Cancer Patients

2020

Abstract Objective To assess the personalized pain intensity goal (PPIG), the achievement of a personalized pain goal response (PPGR), and patients' global impression (PGI) in advanced cancer patients after a comprehensive pain and symptom management. Design Prospective, longitudinal Setting Acute pain relief and palliative/supportive care. Subjects 689 advanced cancer patients. Methods Measurement of Edmonton Symptom Assessment Score (ESAS) and personalized pain intensity goal (PPIG) at admission (T0). After a week (T7) personalized pain goal response (PPGR) and patients' global impression (PGI) were evaluated. Results The mean PPIG was 1.33 (SD 1.59). A mean decrease in pain intensity of …

AdultMalemedicine.medical_specialtyPalliative careAdolescentSymptom assessmentYoung Adult03 medical and health sciences0302 clinical medicineHumansPain ManagementMedicine030212 general & internal medicinePrecision MedicineAcute painAgedPain MeasurementAged 80 and overbusiness.industrySymptom managementMinimal clinically important differenceClinical ResponseGeneral MedicineCancer PainMiddle AgedAdvanced cancerIntensity (physics)Anesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyFemalePain IntensityNeurology (clinical)businessCancer painGoals
researchProduct

Prevalence of opioid-related dysuria in patients with advanced cancer having pain.

2010

The aim of this study was to assess the prevalence of opioid-induced dysuria in patients with advanced cancer having pain and to evaluate the possible factors associated. A consecutive sample of cancer patients admitted to an acute pain relief and palliative care unit during 8 months was surveyed. Most patients (147, 86.5%) were receiving opioids at admission. The mean age was 65.1 (SD 12.2) and 106 patients were males. Twenty-five patients presented with dysuria at admission (of which 22 were taking opioids, 14.9%). Eleven patients were inserted a bladder catheter at admission for urine monitoring and 18 patients had urinary incontinence. During admission, 31 patients presented dysuria (19…

AdultMalemedicine.medical_specialtyPalliative carePopulationPainUrinary incontinenceurologic and male genital diseasesSettore MED/42 - Igiene Generale E ApplicataDysuriaNeoplasmsInternal medicinePrevalenceHumansMedicineDysuriapatients with advanced cancer painPrevalence of opioid-related dysuriaSex DistributioneducationAgedPain Measurementeducation.field_of_studybusiness.industryPalliative CareCancerGeneral MedicineMiddle AgedOpioid-Related Disordersmedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryAnalgesics OpioidOpioidConcomitantFemaletrial clinicomedicine.symptombusinessCancer painPrevalence of opioid-related dysuria; patients with advanced cancer pain; trial clinicomedicine.drug
researchProduct